Bo Liu

Title: Bo Liu: Innovator in Synthetic Peptides and Power Load Monitoring

Introduction

Bo Liu is a prominent inventor based in Tianjin, China. He has made significant contributions to the fields of synthetic peptides and power load monitoring. With a total of 2 patents, Liu's work showcases his innovative approach to solving complex problems in technology and healthcare.

Latest Patents

Liu's latest patents include a synthetic peptide with an amino acid sequence SEQ ID NO: 1, which features a cysteine at its N-terminal. This invention also encompasses an artificial antigen and an antibody specific to the human EHD2 protein. The patent outlines a method for preparing this antibody, which is applicable in immunohistochemical methods for EHD2 detection, as well as in cancer diagnosis and prognosis. Another notable patent is a current pattern matching method for non-intrusive power load monitoring and disaggregation. This method improves the accuracy of disaggregation by establishing a load signature database and optimizing the matching of current patterns, ultimately reducing costs and enhancing appliance state identification.

Career Highlights

Throughout his career, Bo Liu has worked with notable organizations such as Tianjin Yingshibo Technology Development Co., Ltd. and Tianjin University. His experience in these institutions has allowed him to develop and refine his innovative ideas, contributing to advancements in technology and research.

Collaborations

Liu has collaborated with talented individuals such as Yixin Yu and Bing Wang. These partnerships have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking technologies.

Conclusion

Bo Liu's contributions to synthetic peptides and power load monitoring exemplify his innovative spirit and dedication to advancing technology. His patents reflect a commitment to improving healthcare and energy efficiency, making him a noteworthy figure in the field of invention.